The IPVS Policy Committee participates in the development and maintenance of position statements on issues related to papillomaviruses and the development of prevention of their associated diseases. The Committee also comments on new scientific, clinical and policy developments and develop educational professional and public information services, as needed, on behalf of IPVS.
Please find below the policy statements of the IPVS Policy Committee.
| Title | Link |
|---|---|
| COVID-19 as a catalyst for reimagining cervical cancer prevention | Link |
| HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues | Link |
| Equity in cervical cancer prevention: for all and not just for some | View PDF |
| IPVS Policy Statement addressing the burden of HPV disease for Indigenous people | View PDF |
| HPV prevention and control – The way forward | Link |
| IPVS Statement on Temporary HPV vaccine shortage: Implications globally to achieve equity | View PDF |
| Moving towards Elimination of Cervical Cancer as a Public Health Problem | View PDF |
| HPV vaccination of immunocompromised hosts | View PDF |
| IPVS Statement on HPV vaccination and immunocompromised hosts April 2017 | View PDF |
| The Cape Town Declaration on the Prevention of Human Papillomavirus Disease | View PDF |
| IPVS policy vaccine safety statement September 2015 | View PDF |
